Cochrane · systematic review · CD005389
Fluid restriction for treatment of preterm infants with chronic lung disease
Barrington, KJ, Fortin‐Pellerin, E, Pennaforte, T · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
NeonatalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Fluid restricted compared to liberal fluids compared to placebo for treatment of preterm babies with chronic lung disease
Population: treatment of preterm babies with chronic lung disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Duration of oxygen therapy Fluid restricted vs liberal fluids compared to placebo | no estimate extracted | 1 study · 60 participants | Low |
Duration of hospitalisation Fluid restricted vs liberal fluids compared to placebo | no estimate extracted | 1 study · 60 participants | Low |
Daily weight gain Fluid restricted vs liberal fluids compared to placebo | no estimate extracted | 1 study · 60 participants | Low |
Proportion with apnoea Fluid restricted vs liberal fluids compared to placebo | RR 1.35 [0.98, 1.86] | 1 study · 60 participants | Low |